Concept and Practice of Therapeutic Teams: Proceedings of the 11th European Symposium on Clinical Pharmacy, Brussels 1982

Paperback (Print)
Buy New
Buy New from BN.com
$34.60
Used and New from Other Sellers
Used and New from Other Sellers
from $31.27
Usually ships in 1-2 business days
(Save 21%)
Other sellers (Paperback)
  • All (4) from $31.27   
  • New (3) from $31.27   
  • Used (1) from $56.66   

Overview

This 1983 book reports the proceedings of the eleventh European symposium on clinical pharmacy which was held in Brussels in October 1982. The theme of the symposium was the concept of the therapeutic team and the relative contributions and responsibilities of pharmacists, nurses and physicians to the planning and implementation of drug treatment regimens. The first section of the volume provides an introduction to the concept of the therapeutic team and reflects the views several medical professionals. The later sections cover the practice of the therapeutic team in parenteral nutrition, oncology, dermatology, epilepsy, internal medicine, nuclear medicine and drug selection. Not only did this book review achievements and experiences in clinical pharmacy, but it also looked towards the future of clinical pharmacy development in Europe. It will still be of significant interest to clinical pharmacy specialists today.

Read More Show Less

Product Details

  • ISBN-13: 9780521279178
  • Publisher: Cambridge University Press
  • Publication date: 6/9/2011
  • Pages: 266
  • Product dimensions: 6.00 (w) x 8.90 (h) x 0.70 (d)

Table of Contents

Preface; Part I. Introduction: 1. Introductory remarks; Part II. The Concept of the Theraputic Team: 2. The concept of the therapeutic team; 3. The view of a pharmacist; 4. The view of a physician; 5. The view of a nurse; 6. The view of the clinical pharmacologist; 7. The view of an academic; Part III. Practice of the Therapeutic Team: Parenteral Nutrition: 8. Parenteral nutrition - the team approach in a general hospital; 9. Long-term follow-up in total parenteral nutrition; 10. Total parenteral nutrition of children at the State University Hospital of Copenhagen; 11. Compatibility of two different fat emulsions with amino-acids, carbohydrate and electrolytes in parenteral nutrition mixtures; 12. Esophagus cancer and parenteral nutrition: postoperative complications and P. N. I. relationship. Preliminary study; Part IV. Oncology: 13. Central nervous system prohylaxis of acute lymphoblastic leukemia with methotrexate; 14. The treatment protocols of acute lymphoblastic leukemia in children; 15. Guidelines for the safe handling of minibags; 16. Centralization of preparation of cytotoxic drugs in the central pharmacy: one year of experience; 17. Progress in the management of high dose methotrexate; 18. Parmacokinetics of cytosine arabinoside in leukemic patients with normal and impaired hepatic functions, preliminary results; PartV. Dermatology: 19. The operation of a therapeutic team in dermatology; Part VI. Epilepsy: 20. Team treatment of epilepsy; 21. Practices of the therapeutic team in epilepsy; 22. Interdisciplinary approach to the treatment of epilepsy; 23. The role of clinical pharmacist in the monitoring of antiepileptic therapy in clinics with ambulant patients, our experience with 45 patients; Part VII. Internal Medicine - Rheumatology: 24. An approach to the therapeutic strategy in rheumatoid arthritis. Adverse reactions to penicillamine-like drugs used in the treatment of rheumatoid arthritis; Part VIII. Nuclear Medicine: 25. The nuclear medicine team; 26. Practice of the nuclear medicine therapeutic team: the role of the physician; 27. Practice of the nuclear medicine therapeutic team: the role of the physicist; 28. Practice of the nuclear medicine therapeutic team: the role of the radiotherapist; Part IX. Drug Selection: 29. Collaboration in drug selection - preparing the London Hospital Formulary 1982 - guide to the prescribing of medicines: introduction; 30. A clinician's view on the team approach to drug selection; 31. A pharmacists view on the team approach to drug selection; 32. Conclusion; 33. Restrictive formulary management with consequences for the treatment of individual patients; 34. Changes in patterns of analgesic use; Part X. Pharmacokinetics, Dialysis, I. V. Therapy: 35. Clinical pharmacy improvement and interrelation with therapeutci team; 36. Clinical pharmacist participation in a clinical trial - treatment of congestive heart failure; 37. Metronidazole plasma levels after I. V. and rectal administration; 38. Individual factors influencing aminoglycoside serum levels; 39. Monitoring theophylline plasma levels; 40. Comparison of four pharmacokinetic methods for individualizing phenytoin dosage; 41. Use of a calculator program for individualized estimation of pheyoin kinetic parameters by a least-squares technique; 42. On the importance of regular Al determination in patients on regular hemodialysis (RHD); 43. Manufacture of dialysis concentrate at the level of a hospital; 44. Hospital preparation of injectable drugs by means of a multi-additive pump; 45. How to detect physico-chemical incompatabilities in I. V. admixtures; 46. Preparation of an enema containing metaminosalicylic acid

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)